Qualitas (ASX: QAL): Banks Are Retreating From Real Estate — Here's Who's Stepping In

Qualitas (ASX: QAL) is one of Australia's leading real estate alternative investment managers, with $10.9 billion in funds under management and $40 billion in real estate assets financed over 18 years. In this Sharewise investor webinar, Group Managing Director and Co-founder Andrew Schwartz joins Homodeus Research founder Wei to discuss why Qualitas exists at the intersection of Australia's housing shortfall and the banks' structural retreat from real estate lending. Topics covered include: How Qualitas performed through 13 consecutive rate hikes — and why the model works in both rising and falling rate environments The stability of Qualitas' capital base, with more than 90% held in closed-ended or listed structures The recent acquisition of Starz, giving Qualitas its first European platform in a market five times the size of Australia's Qualitas' proprietary AI-enabled credit execution platform and its role in the group's upgraded margin target What recent Federal Budget changes to negative gearing and CGT mean for real estate private credit How institutional investors are re-rating Australia as a destination for real estate credit capital Qualitas' risk management approach and portfolio stress-testing assumptions Important note: This discussion took place during Qualitas' results blackout period. All statements referenced information already publicly disclosed to the ASX, including the Macquarie Australia Conference presentation (5 May 2026), the European expansion announcement (12 June 2026), and the AI initiatives update (26 June 2026). No new financial or performance information was provided, and nothing in this episode constitutes financial product advice. This content has been produced by Homodeus Research (homodeus.one), a Corporate Authorised Representative of Sharewise Pty Ltd (AFSL 280420), under an issuer-pays research model. Qualitas is a current or prospective client of Sharewise/Homodeus Research. This is general information only and does not constitute personal financial product advice. It does not take into account your objectives, financial situation, or needs. Homodeus Research and its representatives may receive fees from the companies covered. Full disclosures are available at homodeus.one.